Study to evaluate 2 types of treatment (masitinib + FOLFIRI or placebo + FOLFIRI) in the treatment of patients with metastatic colorectal cancer that have received 1 previous therapy

Update Il y a 4 ans
Reference: EUCTR2013-000490-79

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Overall survival (OS)


Inclusion criteria

  • Metastatic colorectal cancer after 1 previous line of treatment